FSRH CEU Statement: Response to new study by Meaidi et al (September 2023)
This FSRH Statement responses to a recently published study by Meaidi et al. published on 06/09/2023 which used data from nationwide Danish databases to compare risk of first VTE events during use of hormonal contraception (HC) with that during concomitant use of HC and the non-steroidal anti-inflammatory drugs (NSAIDs) ibuprofen, diclofenac or naproxen.
You are welcome to download our freely available Guideline documents by clicking on the document title above.
This document is up-to-date